Citius Oncology shareholders back election of three Class II directors

Citius Oncology held its annual stockholders meeting on September 29, 2026, with stockholders backing the election of Eugene Holuka, Robert Smith and Carol Webb as Class II directors, and ratifying Wolf & Company, P.C. as independent registered public accounting firm for the fiscal year ended September 30, 2026.